Binx

binx health to Participate in William Blair’s Innovator Series: Life Science Tools and Diagnostics

Retrieved on: 
Monday, December 12, 2022

binx health, a healthcare technology and diagnostics company focused on making routine testing convenient, today announced that Jeff Luber, Chief Executive Officer of binx health, will present a company overview presentation at William Blairs Innovator Series: Life Science Tools and Diagnostics on December 13th, 2022.

Key Points: 
  • binx health, a healthcare technology and diagnostics company focused on making routine testing convenient, today announced that Jeff Luber, Chief Executive Officer of binx health, will present a company overview presentation at William Blairs Innovator Series: Life Science Tools and Diagnostics on December 13th, 2022.
  • The presentation will be followed by a Q&A session led by William Blairs Research team.
  • A link to the recording will be available following the presentation in the News section of the binx health website.
  • The conference highlights exciting private companies in the Life Science Tools and Diagnostics sectors.

binx health Announces Strategic Supply Agreement with Afaxys to Expand Sexual Health Test Access to Thousands of Clinics Nationally

Retrieved on: 
Thursday, November 10, 2022

binx health, a healthcare technology and diagnostics company focused on making routine testing convenient, today announced a strategic agreement with Afaxys Group Services LLC to expand access to sexual health and wellness testing nationally through their Group Purchasing Organization (GPO) .

Key Points: 
  • binx health, a healthcare technology and diagnostics company focused on making routine testing convenient, today announced a strategic agreement with Afaxys Group Services LLC to expand access to sexual health and wellness testing nationally through their Group Purchasing Organization (GPO) .
  • Under the agreement, binx will offer its FDA-cleared, CLIA-waived point-of-care test for chlamydia (CT) and gonorrhea (NG) and its at-home digital health platform to thousands of clinics across the United States, under a preferred pricing model with joint marketing outreach among Afaxys and binx.
  • With this agreement, we will be able to help more patients receive the tests they need in a way that works best for them.
  • We applaud the important work of Afaxys and its member clinics in furthering healthcare access and are thrilled to join their GPO network, said Jeffrey Luber, Chief Executive Officer of binx health.

Amid National Surge in Sexually Transmitted Infections binx health Announces Launch of Reagent Rental Program for Decentralized, Rapid, Point-of-Care Testing Platform for Chlamydia and Gonorrhea

Retrieved on: 
Tuesday, November 1, 2022

This program eliminates all upfront instrument costs, enabling access to rapid testing and helping pave the way to better health outcomes.

Key Points: 
  • This program eliminates all upfront instrument costs, enabling access to rapid testing and helping pave the way to better health outcomes.
  • The company has begun accepting pre-orders under its early access program for Q1 deliveries.
  • Please contact binx today to participate in the early access program and reserve a binx io at [email protected] or visit www.binx-io.com .
  • For a symptomatic male patient with a chlamydia negative test result, further testing with a laboratory-based molecular test is recommended.

Self-Collection Kits Provide Convenient Care for Sexually Transmitted Infections for Residents in All Alabama Counties

Retrieved on: 
Thursday, October 6, 2022

In a first of its kind partnership, the Alabama Department of Public Health (ADPH) and binx health, a healthcare technology and diagnostics company, enable access to routine remote sample collection for sexually transmitted infections (STIs) and subsequent treatment for Alabama residents.

Key Points: 
  • In a first of its kind partnership, the Alabama Department of Public Health (ADPH) and binx health, a healthcare technology and diagnostics company, enable access to routine remote sample collection for sexually transmitted infections (STIs) and subsequent treatment for Alabama residents.
  • View the full release here: https://www.businesswire.com/news/home/20221006005308/en/
    The program consists of STI/HIV self-collection kits made available to order online through the binx everywhere digital platform, then mailed to any Alabama resident.
  • "The Alabama Department of Public Health is very pleased with the results of the initiative, said Anthony Merriweather, STD Director at ADPH.
  • The ADPH will continue to provide the self-collection kits for STI/HIV testing.

binx health CEO, Jeffrey Luber Announced as an EY Entrepreneur Of The Year 2022® New England Award Winner

Retrieved on: 
Thursday, June 9, 2022

Ernst & Young LLP (EY US) today announced that Jeffrey Luber, Chief Executive Officer of binx health, was named an Entrepreneur Of The Year 2022 New England Award winner.

Key Points: 
  • Ernst & Young LLP (EY US) today announced that Jeffrey Luber, Chief Executive Officer of binx health, was named an Entrepreneur Of The Year 2022 New England Award winner.
  • View the full release here: https://www.businesswire.com/news/home/20220609005381/en/
    Ernst & Young LLP (EY US) today announced that Jeffrey Luber, Chief Executive Officer of binx health, was named an Entrepreneur Of The Year 2022 New England Award winner.
  • (Photo: Business Wire)
    It is a true privilege and honor to be named as an EY Entrepreneur of the Year 2022 New England Award Winner," said Jeffrey Luber, Chief Executive Officer of binx health.
  • As a New England award winner, Luber will now be considered by the National independent panel of judges for the Entrepreneur Of The Year 2022 National Awards.

EY Announces Jeff Luber of binx health as an Entrepreneur Of The Year® 2022 New England Award Finalist

Retrieved on: 
Monday, May 9, 2022

Ernst & Young LLP (EY US) announced that Jeff Luber, Chief Executive Officer of binx health, has been named an Entrepreneur Of The Year 2022 New England Award finalist.

Key Points: 
  • Ernst & Young LLP (EY US) announced that Jeff Luber, Chief Executive Officer of binx health, has been named an Entrepreneur Of The Year 2022 New England Award finalist.
  • It is a privilege to be recognized by Ernst & Young as a finalist in their Entrepreneur Of The Year 2022, Luber says.
  • The Entrepreneur Of The Year National Overall Award winner will then move on to compete for the EY World Entrepreneur Of The Year Award in June 2023.
  • EY Private teams offer distinct insights born from the long EY history of working with business owners and entrepreneurs.

binx health and Wellfleet Partner to Broaden Equitable Access to HPV Screening Through the binx everywhere Care Platform

Retrieved on: 
Wednesday, May 4, 2022

binx health, a healthcare technology and diagnostics company focused on making routine testing convenient, has partnered with student health insurer Wellfleet to broaden access to human papillomavirus (HPV) testing through convenient, at-home sample collection.

Key Points: 
  • binx health, a healthcare technology and diagnostics company focused on making routine testing convenient, has partnered with student health insurer Wellfleet to broaden access to human papillomavirus (HPV) testing through convenient, at-home sample collection.
  • The Cancer Moonshot Fact Sheet recognizes that facilitating HPV screening outside the clinic (e.g., through at-home and mobile screening) is critical to reducing barriers and ensuring equitable access.
  • It is gratifying to be shoulder-to-shoulder with an organization as committed to student health as Wellfleet, said Jeff Luber, binx health President and CEO.
  • Wellfleet is the marketing name used to refer to the insurance and administrative operations of Wellfleet Insurance Company, Wellfleet New York Insurance Company, and Wellfleet Group, LLC.

binx health Appoints Life Sciences Veteran Jack Crowley as Chief Financial Officer

Retrieved on: 
Tuesday, April 5, 2022

binx health , a healthcare technology and diagnostics company, announced today the appointment of Jack Crowley as Chief Financial Officer (CFO).

Key Points: 
  • binx health , a healthcare technology and diagnostics company, announced today the appointment of Jack Crowley as Chief Financial Officer (CFO).
  • Crowley brings deep industry expertise in life sciences and demonstrated results in successful initial and secondary public offerings, capital structure enhancements, analyst collaboration, and investor relations.
  • binx health has a vision for healthcare delivery that addresses current gaps in healthcare equity and healthcare access, said Crowley.
  • Before joining binx health, Crowley was the CFO of Ora, Inc, a global leader in full service ophthalmic research.

binx health Voted as Finalist in Medical Design Excellence Awards 2022

Retrieved on: 
Wednesday, March 30, 2022

binx health , a healthcare technology and diagnostics company is pleased to announce its selection as a finalist in the Medical Design Excellence Awards 2022 .

Key Points: 
  • binx health , a healthcare technology and diagnostics company is pleased to announce its selection as a finalist in the Medical Design Excellence Awards 2022 .
  • The Medical Design Excellence Awards (MDEA) is the premier awards program for the medtech industry with a mission to recognize significant achievements in medical product design and engineering that improve the quality of healthcare delivery and accessibility.
  • We are honored to be included in the esteemed list of MDEA 2022 finalists, said Anna Dixon, CTO of binx health.
  • binx healths io was selected as a finalist in the "Testing and Diagnostic Products and Systems" category.

binx health Appoints Industry Veteran Todd Bennett as Chief Commercial Officer

Retrieved on: 
Wednesday, March 16, 2022

binx health , a healthcare technology and diagnostics company that makes routine testing convenient by enabling access to care where people live, work, study, and shop, announced today the appointment of Todd Bennett as Chief Commercial Officer (CCO).

Key Points: 
  • binx health , a healthcare technology and diagnostics company that makes routine testing convenient by enabling access to care where people live, work, study, and shop, announced today the appointment of Todd Bennett as Chief Commercial Officer (CCO).
  • Bennett is an accomplished industry veteran, having held multiple executive leadership roles at several high-growth companies including Luminex, Immucor, Roche and Abbott.
  • We are thrilled to welcome someone of Todds vast accomplishment, operational, and commercial skill to binx, said Jeff Luber, binx health CEO.
  • I am honored to have the exciting opportunity to join binx health at an inflection point in its commercial development, said Bennett.